• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.

作者信息

Cohen Ariel A, Heidbuchel Hein, Le Heuzey Jean-Yves, De Caterina Raffaele, Merino Jose L, Jin James, Melino Michael, Winters Shannon M, Goette Andreas, Lip Gregory Y H

机构信息

Hôpital Saint Antoine, Hôpital Tenon, Université Pierre et Marie Curie (Paris VI), Paris, France.

Antwerp University and University Hospital, Cardiology, Antwerp, Belgium.

出版信息

Am Heart J. 2019 Mar;209:131-135. doi: 10.1016/j.ahj.2018.10.008. Epub 2018 Nov 22.

DOI:10.1016/j.ahj.2018.10.008
PMID:30635112
Abstract
摘要

相似文献

1
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.计划进行电复律的非瓣膜性心房颤动患者的自发转复：心房颤动电复律患者中依度沙班与华法林对比研究（ENSURE-AF）试验的亚组分析
Am Heart J. 2019 Mar;209:131-135. doi: 10.1016/j.ahj.2018.10.008. Epub 2018 Nov 22.
2
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.肾功能与预后的关系：来自依度沙班与华法林用于心房颤动转复受试者（ENSURE-AF）研究的事后分析。
Am Heart J. 2017 Nov;193:16-22. doi: 10.1016/j.ahj.2017.07.010. Epub 2017 Jul 20.
3
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.计划性心脏转复中左心房血栓形成的决定因素：ENSURE-AF 研究分析。
Europace. 2019 Nov 1;21(11):1633-1638. doi: 10.1093/europace/euz213.
4
Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).接受心房颤动复律的华法林治疗患者的抗凝控制（来自依度沙班与依诺肝素 - 华法林用于心房颤动复律试验）
Am J Cardiol. 2017 Sep 1;120(5):792-796. doi: 10.1016/j.amjcard.2017.06.005. Epub 2017 Jun 15.
5
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.艾多沙班与华法林用于心房颤动复律患者的前瞻性比较：艾多沙班与华法林用于心房颤动复律患者（ENSURE-AF）研究
Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21.
6
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.依度沙班与华法林在维生素 K 拮抗剂经验性和非经验性患者中的比较：来自依度沙班与华法林在心房颤动患者电复律（ENSURE-AF）随机试验中的比较。
Clin Res Cardiol. 2020 Aug;109(8):1018-1024. doi: 10.1007/s00392-019-01594-9. Epub 2020 Jan 8.
7
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.依度沙班与依诺肝素 - 华法林用于房颤复律患者的疗效比较（ENSURE - AF）：一项随机、开放标签的3b期试验。
Lancet. 2016 Oct 22;388(10055):1995-2003. doi: 10.1016/S0140-6736(16)31474-X. Epub 2016 Aug 30.
8
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial.在接受心房颤动转复的患者中比较依度沙班与华法林的依度沙班与华法林在电复律（ENSURE-AF）随机试验中联合抗血小板药物对临床结局的影响。
Clin Res Cardiol. 2020 Nov;109(11):1374-1380. doi: 10.1007/s00392-020-01635-8. Epub 2020 Mar 31.
9
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.依度沙班治疗可提高治疗满意度并减少医疗资源的利用：来自房颤患者电复律（ENSURE-AF）研究中依度沙班与华法林的对比分析。
Europace. 2018 Dec 1;20(12):1936-1943. doi: 10.1093/europace/euy141.
10
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).新型 Xa 因子抑制剂依度沙班与华法林治疗心房颤动患者的比较评估：心房颤动-溶栓治疗心肌梗死 48 次新一代 Xa 因子有效抗凝试验（ENGAGE AF-TIMI 48）的设计和原理。
Am Heart J. 2010 Oct;160(4):635-41. doi: 10.1016/j.ahj.2010.06.042.

引用本文的文献

1
Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation.心房颤动患者早期自发转为窦性心律的临床决定因素。
Neth Heart J. 2021 May;29(5):255-261. doi: 10.1007/s12471-020-01528-5. Epub 2021 Jan 6.